Skip to main content

Bringing Stimulants Abroad

Bringing Stimulants Abroad

Last updated:

Stimulants (methylphenidate, MPH, and amphetamine-based medications, AMP) are classified as controlled substances (BtM) in Germany (along with many other substances).1 This article discusses the regulations governing the import of these stimulants from Germany and their possession in other countries.
Further information is available from the Federal Institute for Drugs and Medical Devices (BfArM) at Traveling with Narcotics as well as in the database of the International Narcotics Control Board.

The information compiled here is by no means complete and should be used only as a starting point for further research.
No guarantee of accuracy or timeliness. Rules are subject to change at any time.

1. General Recommendations for Traveling with Stimulants, Controlled Substances, and Cannabinoids

It is strongly recommended that you consult the database of the International Narcotics Control Board as a data source.
In addition, recommendations from the respective countries of travel should be taken into account, even if they are merely additional guidelines, as they can shed light on current legal practice and potential disputes over interpretation. The law is what a court rules. In doing so, your own case may even result in a ruling that puts an end to previous legal practice and establishes a new precedent. Nevertheless, this already applies to the case in which it was first decided. The law has about as much to do with justice as the latest Golf has to do with the perfect car. A perfect car consumes no energy, never breaks down, and is infinitely fast: it is an ideal, not a reality. The law, on the other hand, like cars, is made by people.

The technology behind luggage scanners—such as those used at airports—has advanced. Modern scanners can scan the contents of closed suitcases and carry-on bags and detect even the smallest amounts of amphetamine (e.g., in medications).

It is strongly discouraged to “repackage” controlled substances in plain packaging. This may give rise to the suspicion of deliberate concealment, which constitutes initial grounds for suspicion of criminal activity.

Depending on the country, travelers may be asked about this as early as passport control or the entry interview (e.g., in the U.S.). Since the interview takes place before baggage claim, both the medications and the documentation should be in your carry-on luggage.

As a general rule, it is advisable to contact the respective airline(s) for specific information.
Lufthansa recommends carrying medication in your carry-on luggage.

It is unclear whether, after providing information during the entry interview, one must also report to customs.

For transit trips, you must follow the regulations of the country of departure, the transit country or countries , and the destination country, as a transit (stopover) may require you to check out and check in again.

2. Bringing Stimulants When Traveling to Countries in the Schengen Area

When traveling to EU countries that are members of the Schengen Agreement, narcotics obtained with a doctor’s prescription may be imported and exported as personal travel supplies in quantities reasonable for the duration of the trip.
To do so, you must carry a certificate completed by a doctor ( ) authorizing the transport of narcotics for medical treatment in accordance with Article 75 of the Schengen Implementation Agreement ( ). Download the Schengen Certificate.
A separate form must be created for each medication and each dosage.
For example, if Medikinet capsules in 5 mg, 20 mg, and 30 mg are used (for a dosage of 30-25-0), three separate forms are required.
The certificate must be certified by the state health authority responsible in the respective state. In counties with more than one public health department, only one of them may be responsible.
The following is required for certification:

  • submission of the form
  • You must present your ID card or passport
  • Providing a copy of the prescription can help prevent follow-up questions
  • a fee (e.g., 5 EUR in Berlin, or as much as 35 EUR elsewhere).

The certificate is valid for 30 days from the date of issuance.

In practice, we are not aware of any reports that the lack of a public health certificate has caused problems within the Schengen Area.
But if things go wrong, it can get expensive (missed connecting flight or train, getting stranded at some airport somewhere in the world, a hotel, a new flight, and in the worst-case scenario, even criminal charges… Eastern Europe, in particular, isn’t exactly welcoming due to the drug problem there involving crystal meth and amphetamine-based medications).

Only the people with ADHD may take the items with them; third parties are not permitted to do so.
When traveling by air, medications and a medical certificate should be carried together in your carry-on luggage.

Download the list of the relevant state health authorities in the German federal states.
RKI tool for Searching for Public Health Departments in Germany by ZIP Code.

The countries that are part of the Schengen Agreement are:

  • Belgium
  • Bulgaria (since March 2024, partial implementation)
  • Denmark
  • Germany
  • Estonia
  • Finland
  • France
  • Greece
  • Iceland
  • Italy
  • Croatia (as of January 1, 2023)
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Austria
  • Poland
  • Portugal
  • Romania (since March 2024, partial implementation)
  • Sweden
  • Switzerland
  • Slovakia
  • Slovenia
  • Spain
  • Czech Republic, Czechia (formerly: Czechoslovakia)
  • Hungary

The following are not (any longer) members of the Schengen Agreement:

  • Ireland
  • Cyprus
  • England
  • Scotland

No certified certificate is required for a country under the Schengen Agreement when carrying stimulants or controlled substances that were legally purchased within that country.

However, within a country (especially for drivers), it is advisable to carry a doctor’s note confirming that stimulants have been prescribed. The ADHD ID card from adhspedia can be helpful. When driving in the Czech Republic, Slovakia, Poland, Estonia, and Slovenia (and possibly other countries as well), such a card could, however, pose a risk (see below).

3. Travel to Countries Outside the Schengen Agreement

As a general rule, the following applies to bringing stimulants into countries outside the Schengen Area:
You must comply with the regulations of all transit and destination countries. This applies in all cases when traveling by car, bus, or train. We do not know whether the regulations of countries with connecting airports must also be observed when traveling by air.

  • Contact the relevant country (embassy)
  • If importation and possession are permitted
    • Obtain a multilingual medical certificate
      • including information on
        • active ingredients to be imported and transported
        • Single and daily doses
        • Duration of the trip
      • Carrying narcotics for a maximum of 30 days2
    • Have this certificate certified by the state health authority of the respective state
    • Carry a certified certificate with you throughout the entire trip
  • If importation or possession is not permitted
    • Can prescriptions be written on-site?
    • If a prescription cannot be issued on site:
      • Obtain approval from the Federal Opium Control Board
      • Please note: This is a lengthy process!

A list of requirements can be found at Country-Specific Entry Requirements, International Narcotics Control Board.
Many countries have not yet reported their requirements there.
The requirements listed there should be followed as a matter of priority. Any additional information we provide here may be incorrect or out of date.

Muslim countries, in particular, have draconian penalties for drug possession.3
Bringing stimulants into Arab countries is not without risk without careful preparation, even though they are medications. It is important to get accurate information on this matter.

Egypt

According to an inquiry from the Königsmarck’s practice to the Egyptian Embassy in Germany, as of October 26, 2023, it is possible to transport controlled substances using the “International” form.

To bring prescription medications with you, you must provide a certificate from your treating physician or hospital that includes the following details:

  • English-language copy
  • Doctor’s or hospital’s stamp
  • Patient Information:
    • Name
    • Date of Birth
    • Passport Number/ID Card Number
  • Drug Information
    • Name of the medication
    • Amount of medication carried
  • Duration and Date of the Trip
  • Confirmation of Medical Necessity

Various websites also offer pre-made multilingual forms, which are also accepted.
A certificate from the public health department is required for

  • Medications that fall under the Narcotics Act
  • Cannabis-based medications
  • Medications containing opioids

Certification by the consulate is not required, provided that you are taking only the amount necessary for your own use while on vacation.

When traveling to Egypt, you should always carry your medications in your carry-on luggage along with the corresponding certificate.
It is not necessary to present your medications without being asked when entering or leaving the country.

Azerbaijan

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Azerbaijan in Germany, as of October 25, 2023, it was highly likely* That controlled substances could be transported using the “International” form *. This statement appears to be incorrect.

In post-Soviet states (including Azerbaijan), stimulants for ADHD are often not approved or are heavily regulated. Since they are included on national psychotropic substance lists, importing them without authorization may be considered an illegal import of psychotropic substances.

The embassy had no information regarding the transport of amphetamine-based medications. It recommended taking into account the “statement” issued by the Ministry of Health of the Republic of Azerbaijan.
Law of the Republic of Azerbaijan on the Control of Illicit Trafficking in Narcotic Drugs, Psychotropic Substances, and Precursor Chemicals

In the guidelines for travelers state, on the one hand, that medications for personal use are generally permitted, and on the other hand, that there is a general ban on bringing narcotics into the country.

Carrying amphetamine and levoamphetamine is not permitted: https://www.advantour.com/img/azarbaijan/file/prohibited_medicines.pdf
Dextroamphetamine is not explicitly mentioned, but (like levoamphetamine) it is merely an isomer of amphetamine, which is why it is subject to the ban.
At the same time, the ban also applies to precursors, such as lisdexamfetamine.
Likewise, it is prohibited to carry methylphenidate (referred to as “Methylfenidat” in the list).
This same list includes controlled substances. Amphetamines and methylphenidate are not listed among these; instead, they are listed in the sections on prohibited active ingredients.

Australia

According to an inquiry from the Königsmarck Practice to the Australian Embassy in Germany, as of November 23, 2023, it is possible to bring controlled substances into the country using the “International” form. In addition, on-site registration is required.

For more information, visit https://www.abf.gov.au/entering-and-leaving-australia/can-you-bring-it-in/categories/medicines-and-substances

Belarus

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Belarus in Germany, as of October 26, 2023, it is possible to transport controlled substances using the “International” form. The request must be submitted in Russian along with the required certificates.

List of Narcotic Drugs and Psychotropic Substances Subject to Special Import Regulations (in Russian)
Rules for the Importation of Narcotic Drugs and Psychotropic Substances Listed Above (in Russian)
.
The medical prescription or the doctor’s certificate (certified by the relevant German health authorities) or the certificate issued by the relevant authorities of the country of destination must be presented upon import, along with a certified translation into Belarusian or Russian.
In this case, the limit on the duration or the dose is

  • 7 days for drugs
  • 90 single doses of psychotropic drugs.

For detailed information, we recommend submitting an inquiry to the Belarusian Ministry of Health:
Head of the Department of Pharmaceutical Inspections and Medicine Provision, Ministry of Health,
39 Miasnikova St., 220048 Minsk, Belarus,
Phone: 375 17 222 7081
Phone: 375 17 200 7104
Fax: 375 17 222 6297
Fax: 375 17 200 6390
Email: lreutskaya@belcmt.by
Email: gpyshnik@belcmt.by

Chile

According to an inquiry from the Königsmarck Medical Practice to the Chilean Embassy in Germany, as of September 5, 2023, it is possible to transport controlled substances using the “International” form.
Travelers entering Chile with medications containing controlled substances can find information in English at the following link: https://www.incb.org/documents/Travellers/files/CHI_ENG_2018.pdf

Travelers may carry their medications for personal use, provided that they

  • have a doctor’s note
  • certifying the use of these medications and the respective quantity carried.

If the quantity of medication poses a risk of being seized upon entry, the necessary authorization can be obtained in advance—with sufficient lead time—through the “Electronic System for the Provisional Importation and Classification of Goods” (Sistema Electrónico de Importación Provisional y Clasificación de Mercancías, SIPRO) at https://up.ispch.gob.cl/ (available only in Spanish with a personal account)
The point of contact is the Subdivision for Trade Control, Foreign, Narcotic, and Psychotropic Drugs (Subdepartamento Control Comercio Exterior, Estupefacientes y Psicotrópicos) within the Department of the National Medicines Agency (ANAMED) of the Chilean Institute of Public Health (Instituto de Salud Pública, ISP). The relevant contact information can be found at the link above on the INCB’s Chilean country page.

Georgia

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Azerbaijan in Germany, as of November 20, 2023, it is highly likely* That controlled substances may be transported using the “International” form *.

In post-Soviet countries (including Azerbaijan), stimulants for ADHD are often not approved or are heavily regulated.

The embassy warned that even when importing narcotic or psychotropic substances for personal medical use, extra caution is required to avoid potentially committing a criminal offense under Georgian law. It is strongly recommended that travelers contact the relevant Georgian authorities before entering the country to ensure compliance with the requirements and to obtain any necessary documents for legal importation.

A PDF containing the law and Schedules I, II, III, and IV (of unknown currency) lists amphetamine, dextroamphetamine, levoamphetamine, methylphenidate, THC, and dronabinol as Schedule II active ingredients.
List II includes controlled substances with restricted distribution: controlled substances posing a high medical and social risk that are authorized for medical use in Georgia, their dosage forms, and other substances that are equivalent to them in terms of their medical and social risk and whose distribution is restricted in Georgia.
Accordingly, the active ingredients mentioned appear to be effective under the conditions of the Revenue Service of the Georgian Ministry of Finance:, to be classified there as Schedule II controlled substances.

Competent authority in Georgia.

United Kingdom

According to an inquiry from the Königsmarck’s practice to the British Embassy in Germany, as of July 25, 2023, it is possible to transport controlled substances using the “International” form.

If you are staying in the United Kingdom for a maximum of three months and are carrying a three-month supply or less of prescription medications containing substances classified as “Schedule 2–5 controlled drugs,” you should carry a letter from the doctor who prescribed the medication. You may be asked to present it upon entry.
The letter should include the following information:

  • Patient’s Name
  • Patient’s Address
  • Patient’s Date of Birth
  • Start and End of the Trip
  • List of medications being carried (including dosage and total quantity)

A list of the ingredients in medications that may be imported under these conditions (“Schedule 2–5 controlled drugs”) can be found at https://www.gov.uk/travelling-controlled-drugs.
Currently (March 2026), the list includes, among other substances, amphetamines, lisdexamfetamine, and methylphenidate, as well as tetrahydrocannabinol (delta-THC), but not bupropion.
Additional information may be available at https://www.gov.uk/government/collections/drugs-licensing

Japan

As of September 27, 2024

Methylphenidate may be imported for personal use for up to 30 days without prior notification or accompanying documentation. If the supply is intended to last longer than 30 days, this must be reported via the email address provided. APPLICATION GUIDANCE, Narcotics Control Department: Psychotropic Substances
Modafinil may also be imported in this manner. List of active ingredients that can be imported in this manner.

The FAQs at the bottom of the page explain that lisdexamfetamine (Vyvanse) is considered a raw material for stimulants and must be imported with the appropriate certification. The procedure and required documents are outlined under APPLICATION GUIDANCE, Narcotics Control Department: Psychotropics .
On the linked list of active ingredients that can be imported in this manner , however, lisdexamfetamine is not listed.
We therefore recommend contacting them at the email address provided.

Adderall is not allowed to be imported into Japan at all.
Similarly, medical cannabis may not be imported. However, dronabinol, a synthetically produced cannabinoid, may be imported as a narcotic subject to the requirements described above.

According to an inquiry from the Königsmarck Clinic to the Japanese Embassy in Germany, as of November 9, 2023, it is possible to carry controlled substances by using the “International” form. Additional requirements apply. There are also regulations governing export. Notes from the Embassy:

General Medications:
General Information from the Japanese Ministry of Health, Labor, and Welfare on Bringing Medications into Japan
Link to the online medication registration form (“Create Account”)

Apart from the usual over-the-counter medications (nasal spray, headache pills, etc.), prescription medications must be declared, but only if your stay is longer than one month. Syringes, pens, etc., must generally be declared.
Even for a shorter trip, you should definitely bring a note from your doctor (with a stamp and signature) to prove that you personally need the medication.
Medications should always be taken in their original packaging and accompanied by the package insert.

Importation of Narcotics
The Narcotics Control Department is responsible for this.
All necessary information, registration forms, a list of permitted and prohibited substances, quantity restrictions, etc., can be found at https://www.ncd.mhlw.go.jp/en/application2.html

Canada

According to an inquiry from the Königsmarck Practice to the Canadian Embassy in Germany, as of August 26, 2023, it is possible to transport controlled substances using the “International” form. There are additional requirements:

Official List of Prescription Medications for Human Use from the Government of Canada

Residents of Canada and visitors may import prescription medications into Canada for personal use or for the use of persons in their care for up to 90 days or for a single course of treatment, without needing a special import permit for their own use or for the use of a person in their care with whom they are traveling.

Visitors staying in Canada for more than three months may import an additional 90-day supply of a health product for personal use into Canada by mail or courier every three months.

Visitors to Canada must be prepared to provide proof of their visitor status. Such proof includes documents such as:

  • Copy of passport
  • a student or work visa, or
  • A letter from an employer or a university

If visitors receive the medication (not: a controlled substance!) By mail, the package should include a copy of the documents listed above and indicate on the outside of the package that it is intended for a visitor in Canada.

Health products imported into Canada for personal use must:

  • be in the packaging provided by the hospital or pharmacy
  • be sold in retail stores in its original packaging, or
  • must have the original label (the label must clearly state what type of health product it is and what it contains).

Prescription medications containing controlled substances:

Search the Controlled Drugs and Substances Act and its associated regulations to determine whether your medication contains a controlled substance: Controlled Drugs and Substances Act and the Schedules of Controlled Drugs and Substances

There are 3 types of controlled substances:

  • Narcotics, e.g.:
    • Morphine
    • Oxycodone
    • Methadone
    • Hydromorphone
  • Controlled substances, e.g.:
    • Barbiturates
    • Pentobarbital
    • Amphetamines
    • Anabolic steroids
  • Specific substances, e.g.:
    • Zolpidem
    • Lorazepam
    • Alprazolam

Methylphenidate is a Schedule 3 substance; amphetamines are Schedule 1 substances under the Controlled Drugs and Substances Act.
There are specific requirements for each type of controlled substance.

Requirements for Entering Canada with a Narcotic or Controlled Substance (BtM/kD):

  • The controlled substance was obtained with a doctor’s prescription and is packaged in pharmacy or hospital packaging with the appropriate labeling (label, original blister pack);
  • The label on the pharmacy/hospital package must include:
    • Instructions for Use
    • Patient’s name
    • Regulation Number
    • Name or brand name of the medication
    • Date the pharmacist dispensed the medication
    • Name and address of the pharmacy or pharmacist
    • Name of the doctor who prescribed the medication
    • Amount and strength of the medication per unit, if applicable
  • The controlled substance is in the person’s possession at the time of entry or exit (= not imported on behalf of a third party)
  • The person is importing or exporting the controlled substance for their own use or for the use of a person for whom they are responsible and who is traveling with them, in order to meet the medical needs of the person for whom it was prescribed;
  • The quantity of controlled substances (BtM/kD) imported or exported does not exceed the lesser of a single treatment OR a 30-day supply, based on the usual daily dose prescribed by the physician;
  • For exports: The export does not violate the laws and regulations of the country of destination
  • Upon importation: The controlled substance must be declared to a customs officer at the time of importation into Canada.
  • Individuals may not send products containing a controlled substance or controlled drug to or from Canada by mail or courier. Only dealers who hold a license under the NCR or the FDR may do so.
  • If a person stays in Canada for more than 30 days, they must make arrangements to see a doctor in Canada. Narcotics and controlled substances may not be imported by mail.

Requirements for Entering Canada with a Controlled Substance:

Requirements under the Benzodiazepines and Other Targeted Substances Regulations

If you are a resident of Canada, you may bring in the smallest amount of medication containing a controlled substance:

  • a single treatment with a specific substance, or
  • a 90-day supply of a target substance, based on the usual daily dose

If you are a resident of another country, you may bring a smaller quantity of medication containing a controlled substance with you:

  • a full container of a controlled substance, or
  • a 90-day supply of a controlled substance, based on the usual daily dose, or
  • the usual daily dose (of a controlled substance) for each day of your stay in Canada

The medication must be prescribed by a healthcare professional, such as a doctor, dentist, or nurse.

The label on the medication container (!!!) must include:

  • Instructions for Use
  • Patient’s name
  • Regulation Number
  • Name or brand name of the medication
  • Date the pharmacist dispensed the medication
  • Name and address of the pharmacy or pharmacist
  • Name of the doctor who prescribed the medication
  • Amount and strength of the medication per unit, if applicable

The medications must be intended for you or for a person for whom you are responsible and who is traveling with you.
You must declare the medications to customs upon your arrival in Canada.
The requirements are the same whether you are entering or leaving Canada.

Contacts

  • For questions about entering and leaving Canada with prescription medications that contain narcotics or controlled substances:
    • Exemptions Department, Email: exemption@hc-sc.gc.ca
  • For questions about entering and leaving Canada with prescription medications that contain other controlled substances.
    • Compliance Department, Email: compliance-conformite@hc-sc.gc.ca
  • To obtain information about traveling with prescription medications that do not contain controlled substances.
    • Health Products Border Compliance Program, Email: hpbcp-pcpsf@hc-sc.gc.ca

Colombia

According to an inquiry from the Königsmarck’s practice to the Colombian Embassy in Germany, as of July 18, 2023, it is possible to transport controlled substances using the “International” form.

It is recommended that you bring the form for the doctor’s confirmation and certification by the State Health Department (translated into Spanish) to avoid any problems upon entry.
The medical certificate must describe the contents of the medications in detail.
In addition, it is recommended that you contact the relevant airlines.

Specific inquiries regarding the importation of food and medicine may be directed to the agency responsible for customs matters in Colombia
DIAN (National Tax and Customs Directorate)

Malaysia

According to an inquiry from the Königsmarck’s practice to the Malaysian Embassy in Germany, as of November 20, 2023, it is possible to transport controlled substances using the “International” form.

TRAVELER’S GUIDE TO BRINGING MEDICATION INTO MALAYSIA from the Malaysian Ministry of Health.

The following are generally required:

  • the valid prescription or a letter from the doctor stating
    • Name of the medication
    • Dosage required for travelers
    • amount brought
  • in English; otherwise, a translation must be included

Amphetamines (dextroamphetamine, levoamphetamine) and methylphenidate are classified as controlled substances (page 26 of the following PDF, Regulation 9).
Special rules and specific forms must be followed for carrying, transit, and export:
https://pharmacy.moh.gov.my/sites/default/files/document-upload/poisons-psychotropic-substances-regulations-1989-2-0_0.pdf

Maldives

According to an inquiry from the Königsmarck’s practice to the Malaysian Embassy in Germany, as of November 17, 2023, it is possible to transport controlled substances using the “International” form.

Before entering the country with controlled substances, you must apply for prior authorization by emailing to the Maldives Food and Drug Authority.
A valid prescription must be attached to the email.
Once approved by the authorities, the patient may bring medication for the duration of their stay, along with a doctor’s note.

  • The certificate from the attending physician should include
    • Patient’s name
    • Name of the drug or drugs
    • therapeutic daily dose
  • The certificate must be written in English or supported by an English translation.
  • Contact information for the Department of Medical and Therapeutic Devices.
    • Email: mtg@health.gov.mv
    • Phone: +960 3014316
  • The email should be sent with the Maldives Embassy in Germany in cc

Monaco

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Monaco in Germany, as of September 5, 2023, it is possible to carry controlled substances using either the “International” form or the “Schengen” form.
Monaco is located within the French customs territory and is therefore subject to Article 75 of the Schengen Agreement.
The patient may not have more medication on hand than is needed for 28 days of treatment, which corresponds to the maximum treatment duration that can be prescribed on the prescription for this medication.

Note from ADxS.org:
In Germany, controlled substances can now be prescribed for a period of 3 months. Whether this period also applies to carrying such substances while traveling under the Schengen Agreement should be clarified with the relevant embassy well in advance.

Montenegro

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Montenegro in Germany, as of August 24, 2023, it is possible to transport controlled substances using the “International” form.
The importation of medicines containing controlled substances (drugs) into Montenegro is governed by Article 43 of the Law on the Prevention of Drug Abuse.
A person who crosses the national border,

  • A medication containing drugs may be used in the amount necessary for personal treatment
  • hold for a period of up to 30 days
  • based on the certificate or report from the chosen physician or a physician specializing in mental health.
  • When crossing the national border, the person is required to present to customs authorities a certificate or medical report stating the necessity of possessing the medication, which must not be more than 90 days old.

Nepal

In Nepal, the possession and import of various medications are prohibited. These include

  • Amphetamine-based medications
  • Vitamins in various combinations and reference values

Methylphenidate is not prohibited. We are not aware of any other restrictions on its import or possession.

Download: List of Medications Banned in Nepal.

Philippines

According to an inquiry from the Königsmarck Medical Practice to the Malaysian Embassy in Germany, as of November 30, 2023, it is possible to transport controlled substances using the “International” form.

Patients may bring medication into the Philippines if they have a doctor’s prescription for it.
It should also be possible to present the doctor’s license.
These documents should be in English or translated.

For further questions, please contact Philippine Customs directly or the Philippine Food and Drug Administration.

It is recommended that correspondence be conducted in English.

Thailand

Lisdexamfetamine (Vyvanse) appears to have been classified as a Category II narcotic by the Thai FDA since February 2025.
Previously, there was apparently no classification at all, and only a doctor’s note was required. All the information and testimonials currently available online still refer to this outdated information.

Since lisdexamfetamine has been classified as a narcotic as of February 2025, you must submit an application in advance to carry it: https://permitfortraveler.fda.moph.go.th/nct_permit_main/
The application must be submitted at least 15 days before the trip (and no more than 30 days in advance).

The following is required for the upload when submitting the application:

Upon entry into Thailand, you must report to the Customs Department (Red Channel) and voluntarily present the medication and supporting documentation.

The following information can be found on permitfortraveler: https://permitfortraveler.fda.moph.go.th/nct_permit_main/Upload/NARCO_list_(updated_February 25, 2025)_NEW.pdf
“Check the Drug” on permitfortraveler also indicates that lisdexamfetamine falls into this category.

One person with ADHD reports that the application was approved within two days.

(Thanks to tlb)

Trinidad and Tobago

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Trinidad and Tobago in Germany, as of July 27, 2023, it is possible to transport controlled substances using the “International” form.

  1. Regulations Governing the Importation of Narcotic Drugs: The Dangerous Drugs Act of Trinidad and Tobago
  2. Quantity restrictions for controlled substances: The quantity must correspond to the amount specified on the prescription, as prescribed by the treating physician
  3. Documents or certificates: A copy of the prescription and a letter from the doctor listing the medications the patient needs
  4. Proper Transportation: Medications must be labeled with the patient’s or passenger’s name and the appropriate instructions for use
  5. Other Information: If the patient is under 18 years of age, a statement from the parents or legal guardians must be provided confirming that they are the patient’s legal guardians

Turkey

According to an inquiry from the Königsmarck’s practice to the Turkish Embassy in Germany, as of January 31, 2024, it is possible to transport controlled substances using the “International” form.

In general, all medications and medical devices—with the exception of hemp, cannabis, and marijuana in the form of flowers—may be brought into Turkey by passengers for personal use.
The passenger must present documents proving that these medications must be taken during the trip. Medical certificates issued by a doctor or hospital, or prescriptions written by a doctor, are acceptable in this context. It is also recommended to have a doctor issue a Schengen certificate. The Schengen certificate does not need to be certified by the public health department and is accepted by Turkish authorities because it is an international document.

Passengers may only bring in the amount of medication and pills that they actually need during their stay in Turkey.
There are no other quantity limits for medications. However, there must be no suspicion of commercial trade in these products.

Bringing cannabis, marijuana, and hemp in the form of flowers into the country is not permitted, even for medicinal use. If you need to take cannabis, marijuana, or hemp in the form of flowers for medical reasons, you should temporarily switch to tablets or oil for the duration of your trip to Turkey.

Further information is available from the Turkish Agency for Turkish Agency for Medicines and Medical Devices.

According to information provided by the Turkish Embassy in Berlin in August 2022, a medical certificate is sufficient for the import and possession of stimulants in quantities necessary for the duration of the trip. However, having the certificate authenticated in accordance with the Schengen Agreement does no harm.
The requirements set by the International Narcotics Control Board, on the other hand, are significantly stricter. For example, the certificate must be sent to a Turkish authority 3 days before the start of the trip.

In June 2023, a Turkish embassy in Germany provided the following information:

“In order for passengers to bring medication and medical devices (including dietary supplements) for personal use, they must present a document to customs authorities proving that these medications or medical devices must be taken during the trip. Certificates issued by a doctor or hospital, or prescriptions written by a doctor, are acceptable in this context. It is also recommended to have a doctor issue a Schengen certificate (the Schengen certificate does not need to be certified by the public health department).
At the same time, please note that you may only bring in the amount of medication and pills that you actually need during your stay in Turkey. It is important that there be no suspicion of commercial trade in these products.
The importation of cannabis, marijuana, and hemp in the form of flowers—even for medicinal use—is not permitted.

Until the early 2010s, methylphenidate was not classified as a controlled substance in Turkey.

Ukraine

According to an inquiry from the Königsmarck Medical Practice to the Ukrainian Embassy in Germany, as of December 15, 2023, it is possible to transport controlled substances using the “International” form.

According to the Ministry of Health of Ukraine and the State Customs Service of Ukraine, the procedures and conditions for the movement of goods across Ukraine’s customs border, customs control procedures, and customs clearance of goods are set forth in the Customs Code of Ukraine. Pursuant to Article 369 of the Code, personal items carried by citizens in their carry-on luggage, in supported or unaccompanied baggage, are subject to the obligation to declare them, either verbally or, at the owner’s request or at the request of the customs authority, in writing; but they are not subject to customs duties and are exempt from official control measures as well as from the requirement to present documents and/or information confirming compliance with the established prohibitions and/or restrictions on the movement of goods across Ukraine’s customs border. Article 370 of the Code refers to such personal items, in particular medicines, that are transported (shipped) across the customs border of Ukraine in the manner and within the limits established by the Cabinet of Ministers of Ukraine.
Pursuant to Resolution No. 458 of the Cabinet of Ministers of Ukraine dated May 23, 2012, “On the Scope and Procedure for the Importation of Medicines and Special Infant Formula by Citizens into the Customs Territory of Ukraine,” citizens may import medicines into the customs territory of Ukraine in their carry-on luggage and/or in checked or unsupported baggage in the following quantities:

  • In quantities of no more than five packages of each type per person (with the exception of medicines containing narcotic or psychotropic substances);
  • In an amount that does not exceed the amount specified in the prescription for such a medication, which is issued in the person’s name and certified by the physician’s and/or the healthcare facility’s seal.

In light of the above, the importation of pharmaceuticals, that contain narcotic drugs or psychotropic substances (in particular, methylphenidate Or amphetamine) and are carried in a citizen’s carry-on luggage and/or in their checked or unchecked baggage may be imported into the customs territory of Ukraine if the person

  • one issued in their name and
  • a prescription for such items, confirmed by the signature of a doctor and/or a healthcare facility
  • Possesses a quantity of medication that does not exceed the amount specified in this prescription.***

In addition, Resolution No. 770 of the Cabinet of Ministers of Ukraine, dated May 6, 2000, approved a list of narcotic drugs, psychotropic substances, and precursor chemicals. According to List No. 2 of Table II of the list, the circulation of psychotropic substances such as amphetamine And methylphenidate is restricted. Pursuant to Ukrainian Law No. 60/95-ВР “On Narcotic Drugs, Psychotropic Substances, and Precursors” of February 15, 1995, the distribution of medicinal products containing narcotic drugs and psychotropic substances listed in Tables II and III of the Schedule, is subject to the control measures applicable to the circulation of the narcotic drugs or psychotropic substances contained therein (Article 2). To simplify customs controls for citizens, Article 366 of the Customs Code provides that customs controls for goods brought across the Ukrainian customs border by citizens may be carried out using a two-channel customs control system.
The two-channel system is a simplified customs control system that allows citizens to file declarations by choosing one of the two channels for crossing (in private vehicles) Ukraine’s customs border. The lane marked with green symbols (“green corridor”) is intended for citizens transporting goods across Ukraine’s customs border in quantities that

  • are not subject to customs duties and
  • that are not subject to statutory prohibitions or restrictions on importation into or exportation from the customs territory of Ukraine, and
  • do not require written registration.

The lane marked with red symbols (“red corridor”) is intended for all other citizens. Citizens independently choose the appropriate lane (“green corridor” or “red corridor”) for customs inspection under the two-lane system.
In light of this, these citizens must

  • When importing medicines that contain narcotic drugs or psychotropic substances listed in Tables II and III, select the “red corridor” for customs inspection,
  • Submit a written statement to **** And
  • Submit the documents specified in Resolution 458.

The written declaration, in accordance with the procedure established for citizens, is made using a customs declaration form for the written declaration of goods brought across Ukraine’s customs border by citizens for personal, family, and other needs not related to business activities. The declaration form was approved by Resolution No. 451 of the Cabinet of Ministers of Ukraine dated May 21, 2012, and the procedure for completing it was approved by Order No. 614 of the Ministry of Finance of Ukraine dated May 28,2012, which was registered with the Ministry of Justice of Ukraine on June 20, 2012, under No. 1014/21326.
The list is available on the official website of the Verkhovna Rada of Ukraine at the following link: http://zakon.rada.gov.ua/laws/show/770-2000-п.

Comment from ADxS.org—provided without guarantee:

***Regarding the amount of controlled substances you can bring with you: For longer stays that require larger quantities of medical controlled substances, we would recommend contacting the embassy again as a precaution, even though prescriptions for controlled substances can now cover a period of 3 months. Information provided by the embassy is not binding legal advice and may not take into account, for example, unusual circumstances (such as extended stays).

Based on our review of the version (translated into German by Google in Chrome), it appears that dextroamphetamine, levoamphetamine, methylphenidate, lisdexamfetamine, and medical cannabinoids are subject to the procedures outlined above (prescription, red corridor, etc.).

  • According to Cabinet Resolution 770 of May 7, 2000 pursuant to Cabinet Resolution No. 653 of May 24, 2024 is no longer excluded.
    However, the aforementioned Cabinet Resolution No. 653 does not mention dexamfetamine. It deals only with THC and related substances.
    Since dexamfetamine is listed in the same category as methylphenidate, it should—unless it has been generally prohibited from circulation by another, unmentioned decision—be permitted to be imported into Ukraine under the conditions explained above, just as methylphenidate is.

According to the text of Cabinet Resolution 770, only

  • Isomers and Stereoisomers
  • Esters and Ethers
  • homologs
  • Metabolites
  • Salts of all psychotropic substances listed in the resolution, as well as
  • Plants or parts thereof that contain a substance listed in this list and are subject to the same control measures as that substance,
    subject to the same regulations as methylphenidate and dexamfetamine.

Lidesxamfetamine is a prodrug, which is not specifically mentioned in the list.
However, it could also be a translation issue with Google.
In accordance with the intent and purpose of the regulation, lisdexamfetamine should be included and therefore treated in the same manner as dextroamphetamine.

  • THC (tetrahydrocannabinol) is subject to regulation pursuant to Cabinet Resolution 653 of May 24, 2024, THC is no longer subject to a general import ban but is approved as a medicinal substance under the above-mentioned control conditions (prescription, red corridor, etc.). The same applies to
  • Dronabinol
  • Nabilone
  • Nabiximole

United States

According to information provided by the U.S. Embassy in Berlin and the relevant public health department on January 24, 2025, the following is required:

  • A medical certificate (in English) stating that the medication is being taken on an ongoing basis for medical reasons. There is no specific form for this. It must include:
    • specific name and dosage of the medication
    • the quantity (number of capsules)
    • Patient’s name
    • Home address
    • Date of Birth
    • Doctor’s name
    • The doctor’s address and contact information
    • The doctor’s signature and stamp.
  • A certification from the relevant public health department. The public health department certifies
    • that the physician who issued the certificate actually exists
    • that the doctor is licensed
  • You must bring the appropriate amount of the medication for the duration of your trip in its original container.
    • In the original container = blister pack or can. Outer cardboard packaging is not required.
    • You may only take as much as is necessary for the duration of the trip, as prescribed = no quantities that differ significantly from the duration of the trip
    • Otherwise, there is a risk that U.S. authorities could allege an intent to engage in illegal drug trafficking

According to the public health department, it is not necessary to actively present the documents upon entry. It is sufficient to present them if asked to do so.

The required information can also be found on the U.S. Customs and Border Protection website (Link: Traveling with Medication).

Many thanks to Paulina :-)

United Arab Emirates (UAE)

There are import restrictions and bans in place, including for methylphenidate.
Illegal importation of medications can result in prison sentences.
Before entering the country, you can apply for a separate import permit at the appropriate consulates general.

According to an inquiry from the Königsmarck Medical Practice to the Embassy of the United Arab Emirates in Germany, as of January 22, 2024, it is possible to transport controlled substances using the “International” form. Additionally, prior registration is required.

Information on bringing medication with you (whether controlled substances or other prescription drugs) can be found at https://mohap.gov.ae/en

Cyprus

According to an inquiry from the Königsmarck Medical Practice to the Embassy of Cyprus in Germany, as of September 28, 2023, it is possible to carry medical cannabis or medical controlled substances by using the “International” form.
The importation of medical cannabis or medical narcotics requires prior authorization from the Minister of Health. To obtain this authorization, the following must be submitted (by email or fax):

  • The completed application form
  • A doctor’s note stating which medication is being taken and for which condition
  • Authorization from the German authorities entitling the holder to possess and use medical cannabis (medical narcotics)
  • A copy of the prescription

Cannabis is a controlled substance in Cyprus under the Narcotic Drugs and Psychotropic Substances Act of 1977 and the Narcotic Drugs and Psychotropic Substances Regulations of 1979. The importation of (non-medical) cannabis containing even trace amounts of tetrahydrocannabinol (THC) is therefore prohibited in any form.

4. Driving While on Medication

Driving under the influence of stimulants is reportedly illegal in Germany as well, though we do not yet have any further details.

In criminal proceedings under national law concerning the medically necessary and permissible use of medications (which, as in the case of ADHD, enhance traffic safety), it would be necessary to examine on a case-by-case basis whether the applicable national regulations violate higher-ranking European law.

4.1. Czech Republic: Total Ban on Stimulants While Driving

A statement from the Czech Ministry of the Interior confirmed that any detection of amphetamines in the blood can result in criminal charges and the loss of one’s driver’s license.
Lisdexamfetamine has been on the Czech list of controlled substances since 2017; driving a motor vehicle while under the influence of this substance is prohibited.
Methylphenidate is also affected.

Land Transportation Act, PART ONE, TITLE VI, § 125c

“These substances are included on the list of narcotics and psychotropic substances (Government Regulation No. 463/2013, List No. 5). The driver may not operate a motor vehicle immediately after ingesting these substances or while under their influence.”4

This applies quite explicitly even when such side effects result from the proper use of prescribed ADHD medications.
There are different levels depending on the concentration of the active ingredient in the blood, but even at the lowest measurable blood concentration, the penalty for drivers is severe. In the Czech Republic, drivers face a fine of 1,000 to 2,000 euros and a driving ban of 1 to 2 years. So far, however, there are no recorded cases in the statistics of the Czech police prosecuting drivers for using lisdexamfetamine.

The Czech Ministry of Health is aware that the active ingredient is used as a medication for ADHD. However, lisdexamfetamine is not available in the Czech Republic, and there are no plans to approve it.

We assume that this is likely to apply even more so to attentin or amphetamine salts.

(Thanks to Pedro)

Given that traceability is still required under5

  • up to 43 hours after a single dose of methylphenidate
  • up to 83 hours after a single dose of amphetamine-based medications
    This constitutes a serious disadvantage for people with ADHD.

4.2. Estonia: Total Ban on Stimulants While Driving

The laws in the Czech Republic, Estonia, Poland, Slovenia, and Slovakia penalize driving while under the influence of any trace of a substance, even if it is a medication.6

(Thanks to Pedro)

Given that traceability is still required under5

  • up to 43 hours after a single dose of methylphenidate
  • up to 83 hours after a single dose of amphetamine-based medications
    This constitutes a serious disadvantage for people with ADHD.

4.3. Poland: Total Ban on Stimulants While Driving

The laws in the Czech Republic, Estonia, Poland, Slovenia, and Slovakia penalize driving while under the influence of any trace of a substance, even if it is a medication.6

(Thanks to Pedro)

Given that traceability is still required under5

  • up to 43 hours after a single dose of methylphenidate
  • up to 83 hours after a single dose of amphetamine-based medications
    This constitutes a serious disadvantage for people with ADHD.

4.4. Slovenia: Total Ban on Stimulants While Driving

The laws in the Czech Republic, Estonia, Poland, Slovenia, and Slovakia penalize driving while under the influence of any trace of a substance, even if it is a medication.6

(Thanks to Pedro)

Given that traceability is still required under5

  • up to 43 hours after a single dose of methylphenidate
  • up to 83 hours after a single dose of amphetamine-based medications
    This places people with ADHD at a serious disadvantage.

4.5. Slovakia: Total Ban on Stimulants While Driving

The laws in the Czech Republic, Estonia, Poland, Slovenia, and Slovakia penalize driving while under the influence of even trace amounts of a stimulant, even if it is a medication.6
Given that traceability is still required under5

  • up to 43 hours after a single dose of methylphenidate
  • up to 83 hours after a single dose of amphetamine-based medications
    This constitutes a serious disadvantage for people with ADHD.

5. Drug Tests and ADHD Medications

Drug abuse screening using nonspecific point-of-care immunoassay methods (“rapid tests”) can lead to false positives with ADHD medications.
There are barely any studies that examine the risk of “false-positive” test results in immunoassay tests for patients being treated with atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil. Bupropion is reported to cause “false-positive” immunoassay results.
There is a lack of systematic, up-to-date evaluations and validations of cross-reactivity patterns for immunoassays. Using advanced laboratory methods, it is possible to distinguish between prescription medications and illicit amphetamines through stereospecific analysis of dextro- and levoamphetamine; however, these analytical services are not widely available for routine drug testing. In cases of “presumptively” positive immunoassay screening results, a confirmatory laboratory analysis should always be performed.7

A laboratory study found evidence of the in vivo conversion of medical dextroamphetamine to methamphetamine via N-methylation in humans. 31% of the urine samples contained dextromethamphetamine, albeit at levels below 1%. Metabolism via this pathway therefore occurs in such small quantities that it is likely medically irrelevant; however, it is significant for the detection of amphetamine when drug use is suspected. No methamphetamine was found during the in vitro metabolism of lisdexamfetamine or dextroamphetamine (neither dMeth nor lMeth). Among methamphetamine drugs, a racemic mixture of levo- and dextromethamphetamine was not typically found; instead, the vast majority consisted of pure lMeth or dMeth.89

Some prescription drugs that are no longer approved are converted into amphetamine or methamphetamine in the body. The drugs mentioned here include amfetaminil, benzphetamine, clobenzorex, famprofazone, fenethylline, fenproporex, and prenylamine.9
Also available is selegiline (deprenyl) for the treatment of Parkinson’s disease, which is metabolized in vivo to L-methamphetamine and then to L-amphetamine.10


  1. Anlage zum BtmG

  2. Download Stand 04.10.2022

  3. http://www.ads-hyperaktivitaet.de/FAQ/Infos/Medis/medis.html#1

  4. Regierungsverordnung Nr. 463/2013 Slg.; Verordnung der Regierung über Suchtmittellisten

  5. Helland A, Muller S, Spigset O, Krabseth HM, Hansen M, Skråstad RB (2025): Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers. J Anal Toxicol. 2025 Feb 15;49(2):65-72. doi: 10.1093/jat/bkae097. Erratum in: J Anal Toxicol. 2025 Mar 10;49(3):e1. doi: 10.1093/jat/bkaf008. PMID: 39697138.

  6. Office for Official Publications of the European Communities; European Monitoring Centre for Drugs and Drug Addiction, 2009

  7. Jensen CM, Breindahl T (2019): Patients in medical treatment for attention deficit/hyperactivity disorder (ADHD): Are they at risk in drug screening? Atten Defic Hyperact Disord. 2019 Sep;11(3):333-340. doi: 10.1007/s12402-018-0282-9. PMID: 30536198.

  8. Helander A, Andersson A, Villén T (2025): Origin and Interpretation of Low Methamphetamine Levels Found in Amphetamine-Positive Urine Samples: Support for Methylation of Amphetamine as a Minor Metabolic Pathway. Drug Test Anal. 2025 Nov;17(11):2276-2282. doi: 10.1002/dta.3940. PMID: 40776552; PMCID: PMC12580171.

  9. Helander A, Andersson A, Villén T (2025): Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023. Drug Test Anal. 2025 Jan;17(1):163-169. doi: 10.1002/dta.3690. PMID: 38600633; PMCID: PMC11729626.

  10. Shin I, Choi H, Kang S, Kim J, Park Y, Yang W (2021): Detection of l-Methamphetamine and l-Amphetamine as Selegiline Metabolites. J Anal Toxicol. 2021 Feb 6;45(1):99-104. doi: 10.1093/jat/bkaa058. PMID: 32476010.